Richard Rosania, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3500 Arendell St, Morehead City, NC 28557 Phone: 252-726-4697 |
Dr. Debra Reid Mccutcheon, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5053 Executive Dr, Ste B, Morehead City, NC 28557 Phone: 336-716-2255 |
Dr. Matthew John Swiber, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4251 Arendell St Ste B, Morehead City, NC 28557 Phone: 252-222-3340 Fax: 252-222-3245 |
Michael Kline, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3500 Arendell St, Morehead City, NC 28557 Phone: 252-726-4697 |
Steven Richardson, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3500 Arendell St, Morehead City, NC 28557 Phone: 252-726-4697 |
Dr. Garlon L Campbell Jr., MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 534 N 35th St, Suite A, Morehead City, NC 28557 Phone: 252-773-0614 Fax: 252-772-0617 |
News Archive
IRIN reports on HIV prevention efforts aimed at injecting drug users (IDUs) in Thailand, noting HIV prevalence among Thai IDUs is "among the highest in the Southeast Asia region, according to the Global AIDS Response progress report by" UNAIDS.
New research into the treatment and prognosis of gastrointestinal cancers was released today in advance of the tenth annual Gastrointestinal Cancers Symposium being held January 24-26, 2013, at The Moscone West Building in San Francisco, CA.
"Too much cancer screening, too many heart tests, too many cesarean sections. A spate of recent reports suggest that too many Americans - maybe even President Barack Obama - are being overtreated." Defensive medicine and a culture focusing on medical technology have lead to overtesting but "now new evidence and guidelines are recommending a step back and more thorough doctor-patient conversations about risks and benefits."
Sigma-Aldrich Corporation and Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced a major expansion of their existing license agreement to include the exclusive rights to develop and distribute zinc finger DNA binding protein (ZFP)-modified cell lines for commercial production of protein pharmaceuticals.
› Verified 9 days ago